Literature DB >> 15003188

Immunological tolerance loss vs. erythrocyte self antigens and cytokine network disregulation in autoimmune hemolytic anaemia.

Enzo Fagiolo1.   

Abstract

Recent studies on animal and human autoimmune hemolytic anaemia (AIHA) suggest that the loss of immunological tolerance vs. erythrocyte (Er) self antigens (Ag) may be primed by different mechanisms: ignorance of Er self Ag, molecular mimicry between self and non-self Ag, polyclonal T and/or B cells activation, errors in central or peripheral tolerance, immunoregulatory disturbances including the alteration of cytokines network. In vitro stimulation by synthetic Rh peptides indicates that ignorant T and/or B cells from patients with AIHA may recognize criptic Er self Ag. The AIHA associated with bacterial or viral infections seems to be produced by polyclonal T and/or B cell activation against foreign Ag that mimics protein or carbohydrate epitopes on Er. Polyclonal activation of host B cell clones by donor T cells causes the AIHA in chronic graft-versus-host disease. Mouse lines expressing a transgene with autoantibody (autoAb) activity against murine Er have shown that non-deleted peripheral B cell clones may produce Er autoAb. In human a genetic defect of Fas/FasL autoreactive lymphocyte apoptosis may be associated with AIHA. Th1/Th2 cytokines or IL10/IL12 imbalance may induce AIHA: in NZB mice and in human AIHA there is an increased production of Th2 cytokines such as IL4 and IL10 but INF-gamma and IL12 reduced production. Particularly, IL10 seems to act as critical mediator for the Er autoAb production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003188     DOI: 10.1016/S1568-9972(03)00085-5

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  11 in total

Review 1.  Cell-cell communication via extracellular membrane vesicles and its role in the immune response.

Authors:  Inkyu Hwang
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

2.  Therapy for chronic cold agglutinin disease: perspective for further improvements.

Authors:  Sigbjørn Berentsen
Journal:  Blood Transfus       Date:  2013-01-22       Impact factor: 3.443

3.  Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin.

Authors:  Sandra D Algaze; Wungki Park; Thomas J Harrington; Raja Mudad
Journal:  BMJ Case Rep       Date:  2018-03-09

4.  The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Authors:  Ibrahim Ahmed; Jun Teruya; Cristina Murray-Krezan; Robert Krance
Journal:  Pediatr Transplant       Date:  2015-03-23

Review 5.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

Review 6.  Role of Complement in Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

Review 7.  New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia.

Authors:  Wilma Barcellini
Journal:  Transfus Med Hemother       Date:  2015-09-07       Impact factor: 3.747

8.  Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.

Authors:  Sreoshi Chatterjee; Nitin Bhardwaj; Rajiv K Saxena
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

Review 9.  Immunotherapy treatments of warm autoimmune hemolytic anemia.

Authors:  Bainan Liu; Wangang Gu
Journal:  Clin Dev Immunol       Date:  2013-09-11

10.  High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias.

Authors:  Donjete Simnica; Simon Schliffke; Christoph Schultheiß; Nicola Bonzanni; Lorenzo F Fanchi; Nuray Akyüz; Barbara Gösch; Christian Casar; Benjamin Thiele; Janina Schlüter; Ansgar W Lohse; Mascha Binder
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.